Evidence map›Paper›PMID 37190904›Full record

ArticleStatistics in medicine2023

A double-Cox model for non-proportional hazards survival analysis with frailty.

Alexander Begun, Elena Kulinskaya, Njabulo Ncube

Abstract read
In one paragraph

Article in Statistics in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexander BegunSchool of Computing Sciences, University of East Anglia, Norwich, UK.ORCID 0000-0002-2886-2118
Elena KulinskayaSchool of Computing Sciences, University of East Anglia, Norwich, UK.ORCID 0000-0002-9843-1663
Njabulo NcubeSchool of Computing Sciences, University of East Anglia, Norwich, UK.ORCID 0000-0003-3682-0249

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cox regression, a semi-parametric method of survival analysis, is extremely popular in biomedical applications. The proportional hazards assumption is a key requirement in the Cox model. To accommodate non-proportional hazards, we propose to parameterize the shape parameter of the baseline hazard function using the additional, separate Cox-regression term which depends on the vector of the covariates. This parametrization retains the general form of the hazard function over the strata and is similar to one in Devarajan and Ebrahimi (Comput Stat Data Anal. 2011;55:667-676) in the case of the Weibull distribution, but differs for other hazard functions. We call this model the double-Cox model. We formally introduce the double-Cox model with shared frailty and investigate, by simulation, the estimation bias and the coverage of the proposed point and interval estimation methods for the Gompertz and the Weibull baseline hazards. For real-life applications with low frailty variance and a large number of clusters, the marginal likelihood estimation is almost unbiased and the profile likelihood-based confidence intervals provide good coverage for all model parameters. We also compare the results from the over-parametrized double-Cox model to those from the standard Cox model with frailty in the case of the scale-only proportional hazards. The model is illustrated on an example of the survival after a diagnosis of type 2 diabetes mellitus. The R programs for fitting the double-Cox model are available on Github.

Indexed as

Diabetes Mellitus, Type 2FrailtyHumansLikelihood FunctionsProportional Hazards ModelsSurvival AnalysisCox regressionmarginal likelihoodparametric survival analysisshape and scale modelingshared frailty

Identifiers

PMID37190904
PMCPMC10946853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.